JP2025500308A - 哺乳類ｓｌｃ６ａ１９機能の小分子阻害剤 - Google Patents
哺乳類ｓｌｃ６ａ１９機能の小分子阻害剤 Download PDFInfo
- Publication number
- JP2025500308A JP2025500308A JP2024537016A JP2024537016A JP2025500308A JP 2025500308 A JP2025500308 A JP 2025500308A JP 2024537016 A JP2024537016 A JP 2024537016A JP 2024537016 A JP2024537016 A JP 2024537016A JP 2025500308 A JP2025500308 A JP 2025500308A
- Authority
- JP
- Japan
- Prior art keywords
- compound
- substituted
- alkyl
- cycloalkyl
- mmol
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
- C07D401/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
- C07D401/04—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings directly linked by a ring-member-to-ring-member bond
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
- A61K31/505—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim
- A61K31/506—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim not condensed and containing further heterocyclic rings
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/53—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with three nitrogens as the only ring hetero atoms, e.g. chlorazanil, melamine
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
- C07D401/14—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing three or more hetero rings
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D413/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms
- C07D413/14—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing three or more hetero rings
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- Veterinary Medicine (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Epidemiology (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Diabetes (AREA)
- Hematology (AREA)
- Obesity (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US202163292818P | 2021-12-22 | 2021-12-22 | |
| US63/292,818 | 2021-12-22 | ||
| PCT/US2022/053798 WO2023122267A2 (en) | 2021-12-22 | 2022-12-22 | Small molecule inhibitors of mammalian slc6a19 function |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| JP2025500308A true JP2025500308A (ja) | 2025-01-09 |
| JP2025500308A5 JP2025500308A5 (https=) | 2026-01-06 |
Family
ID=86903643
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2024537016A Pending JP2025500308A (ja) | 2021-12-22 | 2022-12-22 | 哺乳類ｓｌｃ６ａ１９機能の小分子阻害剤 |
Country Status (5)
| Country | Link |
|---|---|
| US (1) | US20250084054A1 (https=) |
| EP (1) | EP4452943A4 (https=) |
| JP (1) | JP2025500308A (https=) |
| CN (1) | CN118829628A (https=) |
| WO (1) | WO2023122267A2 (https=) |
Cited By (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JP2025533713A (ja) * | 2022-12-12 | 2025-10-09 | シェブロン ユー．エス．エー． インコーポレイテッド | 石油精製ユニットに供給するための廃プラスチックと石油原料の安定したブレンドのプロセス及びその調製プロセス |
Families Citing this family (6)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| EP4304586A4 (en) | 2021-03-10 | 2025-04-02 | Jnana Therapeutics Inc. | SMALL MOLECULE INHIBITORS OF MAMMALIAN SLC6A19 FUNCTION |
| WO2025196623A1 (en) | 2024-03-21 | 2025-09-25 | Pfizer Inc. | Indole analogs |
| TW202547506A (zh) * | 2024-04-10 | 2025-12-16 | 大陸商長春金賽藥業有限責任公司 | Ｓｌｃ６ａ１９抑制劑化合物、藥物組合物及其製備方法和用途 |
| WO2025217521A1 (en) * | 2024-04-12 | 2025-10-16 | Jnana Therapeutics Inc. | Treating chronic kidney disease with a combination of a slc6a19 inhibitor and a glp-1 agonist |
| US20250346567A1 (en) | 2024-05-13 | 2025-11-13 | Pfizer Inc. | Substituted pyridine and phenyl compounds |
| WO2026038155A1 (en) | 2024-08-16 | 2026-02-19 | Pfizer Inc. | Substituted pyridine compounds |
Family Cites Families (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| EP4304586A4 (en) * | 2021-03-10 | 2025-04-02 | Jnana Therapeutics Inc. | SMALL MOLECULE INHIBITORS OF MAMMALIAN SLC6A19 FUNCTION |
-
2022
- 2022-12-22 JP JP2024537016A patent/JP2025500308A/ja active Pending
- 2022-12-22 CN CN202280091961.0A patent/CN118829628A/zh active Pending
- 2022-12-22 EP EP22912482.1A patent/EP4452943A4/en active Pending
- 2022-12-22 US US18/723,012 patent/US20250084054A1/en active Pending
- 2022-12-22 WO PCT/US2022/053798 patent/WO2023122267A2/en not_active Ceased
Cited By (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JP2025533713A (ja) * | 2022-12-12 | 2025-10-09 | シェブロン ユー．エス．エー． インコーポレイテッド | 石油精製ユニットに供給するための廃プラスチックと石油原料の安定したブレンドのプロセス及びその調製プロセス |
Also Published As
| Publication number | Publication date |
|---|---|
| WO2023122267A3 (en) | 2023-08-03 |
| CN118829628A (zh) | 2024-10-22 |
| US20250084054A1 (en) | 2025-03-13 |
| WO2023122267A2 (en) | 2023-06-29 |
| EP4452943A2 (en) | 2024-10-30 |
| EP4452943A4 (en) | 2025-10-15 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JP7731021B1 (ja) | 哺乳動物ｓｌｃ６ａ１９機能の小分子阻害剤 | |
| JP2025500308A (ja) | 哺乳類ｓｌｃ６ａ１９機能の小分子阻害剤 | |
| JP2025531160A (ja) | Ｓｌｃ６ａ１９機能のスピロ置換ピペリジン阻害剤及び他のピペリジン阻害剤によるｐｋｕの処置 | |
| JP2025524655A (ja) | 哺乳動物のｓｌｃ６ａ１９機能に対する低分子阻害剤 | |
| JP2025531154A (ja) | 哺乳類ｓｌｃ６ａ１９機能のコレクターを用いるｐｋｕの処置 | |
| WO2020061473A1 (en) | Small molecules targeting mutant mammalian proteins | |
| JP2025540072A (ja) | Ｓｌｃ６ａ１９機能のピペリジン阻害剤の結晶形態 | |
| AU2024324395A1 (en) | Bicyclic heteroaryl-containing piperidine inhibitors of slc6a19 function | |
| JP2025523074A (ja) | 哺乳動物のｓｌｃ６ａ１９機能に対する低分子阻害剤 | |
| CN121712506A (zh) | Slc6a19功能的含萘基哌啶抑制剂 | |
| WO2020061476A1 (en) | Small molecules targeting mutant mammalian proteins | |
| WO2022020247A1 (en) | Small molecule correctors of mammalian slc6a8 function | |
| BR112023018277B1 (pt) | Compostos inibidores de pequenas moléculas da função de slc6a19 de mamíferos, e seu uso | |
| BR122025025720A2 (pt) | Composições farmacêuticas compreendendo compostos inibidores de pequenas moléculas da função de slc6a19 de mamíferos | |
| WO2022221182A1 (en) | Small molecule inhibitors of mammalian slc34a1 function | |
| WO2025226887A1 (en) | Diaminomethylene-containing agonists of the parathyroid hormone 1 receptor | |
| WO2026050147A1 (en) | Diaminomethylene-containing agonists of the parathyroid hormone 1 receptor | |
| CN117015378A (zh) | 哺乳动物slc6a19功能的小分子抑制剂 |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| RD03 | Notification of appointment of power of attorney |
Free format text: JAPANESE INTERMEDIATE CODE: A7423 Effective date: 20250212 |
|
| RD04 | Notification of resignation of power of attorney |
Free format text: JAPANESE INTERMEDIATE CODE: A7424 Effective date: 20250214 |
|
| A521 | Request for written amendment filed |
Free format text: JAPANESE INTERMEDIATE CODE: A523 Effective date: 20251209 |
|
| A621 | Written request for application examination |
Free format text: JAPANESE INTERMEDIATE CODE: A621 Effective date: 20251209 |